Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Amy Flaxman

A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector

scientific article published on 21 May 2020

Antibody evasion by the P.1 strain of SARS-CoV-2

scientific article

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques

scientific article published on 14 May 2020

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

scientific article published on 30 July 2020

Development of persistent gastrointestinal S. aureus carriage in mice.

scientific article published on 29 September 2017

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

scientific article published on 10 March 2022

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

scientific article

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

scientific article

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera

scientific article published in February 2021

Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination

article

Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis

scientific article published on September 2010

Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man

scientific article published on 21 July 2018

Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation

scientific article (publication date: 16 May 2016)

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

scientific article

Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion.

scientific article published on 24 February 2016

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

scientific article

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study

scientific article

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies

scientific article published on 16 March 2021

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

scientific article published on 22 March 2019

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

scientific article published on 18 November 2020

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

scientific article published on 20 April 2020

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

scientific article published on 20 July 2020

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

scientific article published in February 2021

Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease

scientific article published on 28 November 2018

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax

scientific article

Paulina is supported by:

About Paulina

Help